← Leaderboards
Oliver John Semmes
University Of Virginia Charlottesville
$10,889,152
Attributed
$12,567,655
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,878,910 · 15
By mechanism
U01$7,259,650 · 2
U2C$5,323,203 · 6
R01$2,946,403 · 1
S10$349,654 · 6
Top collaborators
- Paul Christopher Boutros12 shared
- Thomas Kislinger11 shared
Others in their field
Top investigators on “Early Diagnosis”
- Michael W Weiner · Northern California Institute Res &Educ$162,576,753
- Mitchell D Schnall · University Of Pennsylvania$148,421,012
- David Heimbrook · Leidos Biomedical Research, Inc.$98,656,722
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$85,695,840
- Sharon A Nachman · Johns Hopkins University$77,262,665
- Peter J O'Dwyer · University Of Pennsylvania$75,791,391
Research focus
Early DiagnosisMolecularResearch PersonnelLaboratoriesMalignant NeoplasmsEarly Detection Research NetworkProteinsBiological MarkersProstateBaseMass Spectrum AnalysisProgramsMalignant Neoplasm Of ProstateUrineIndolentBiomarker DevelopmentResourcesCohortProteomicsLiquid SubstanceData SetPerformanceRisk StratificationValidation
Grant awards (53)
Virginia-UCLA-Toronto Biomarker Characterization Center$843,355
U2C · FY2025 · CA · contact PI
Biomarker Discovery & Validation for Early Localized Prostate Cancer Administrative Core$384,714
U2C · FY2025 · CA · contact PI
Core-Biomarker Reference Laboratory$358,748
U2C · FY2025 · CA · contact PI
Virginia-UCLA-Toronto Biomarker Characterization Center$801,603
U2C · FY2024 · CA · contact PI
Core-Biomarker Reference Laboratory$333,610
U2C · FY2024 · CA · contact PI
Biomarker Discovery & Validation for Early Localized Prostate Cancer Administrative Core$330,184
U2C · FY2024 · CA · contact PI
Virginia-UCLA-Toronto Biomarker Characterization Center$569,990
U2C · FY2023 · CA · contact PI
Biomarker Discovery & Validation for Early Localized Prostate Cancer Administrative Core$345,371
U2C · FY2023 · CA · contact PI
Virginia-UCLA-Toronto Biomarker Characterization Center$257,353
U2C · FY2023 · CA · contact PI
Biomarker Discovery & Validation for Early Localized Prostate Cancer Administrative Core$103,273
U2C · FY2023 · CA · contact PI
Core-Biomarker Reference Laboratory$97,493
U2C · FY2023 · CA · contact PI
Core-Biomarker Reference Laboratory$42,626
U2C · FY2023 · CA · contact PI
Virginia-UCLA-Toronto Biomarker Characterization Center$664,127
U2C · FY2022 · CA · contact PI
Core-Biomarker Reference Laboratory$96,984
U2C · FY2022 · CA · contact PI
Biomarker Discovery & Validation for Early Localized Prostate Cancer Administrative Core$93,772
U2C · FY2022 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$220,035
U01 · FY2021 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$127,627
U01 · FY2021 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$433,053
U01 · FY2020 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$420,061
U01 · FY2019 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$432,349
U01 · FY2018 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$430,450
U01 · FY2017 · CA · contact PI
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$454,179
U01 · FY2016 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$218,782
R01 · FY2016 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$218,782
R01 · FY2015 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$212,219
R01 · FY2014 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$205,655
R01 · FY2013 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$218,782
R01 · FY2012 · CA · contact PI
Early Detection of Cancer By Affinity Mass Spectrometry$409,141
U01 · FY2009 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$210,269
R01 · FY2009 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$105,523
R01 · FY2009 · CA · contact PI
Early Detection of Cancer By Affinity Mass Spectrometry$557,923
U01 · FY2008 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$210,269
R01 · FY2008 · CA · contact PI
Early Detection of Cancer By Affinity Mass Spectrometry$535,858
U01 · FY2007 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$210,269
R01 · FY2007 · CA · contact PI
Early Detection of Cancer By Affinity Mass Spectrometry$642,610
U01 · FY2006 · CA · contact PI
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$216,549
R01 · FY2006 · CA · contact PI
Early Detection of Cancer By Affinity Mass Spectrometry$653,548
U01 · FY2005 · CA
HTLV-1 Tax Disrupts DNA Damage Repair-Response Complexes$221,760
R01 · FY2005 · CA
Early Detection of Cancer By Affinity Mass Spectrometry$527,202
U01 · FY2004 · CA
Typhoon 9410 Gel/Blot Imager$174,827
S10 · FY2004 · RR
TYPHOON 9410 GEL/BLOT IMAGER, PROTEOMICS: PHYSIOLOGY$52,448
S10 · FY2004 · RR
TYPHOON 9410 GEL/BLOT IMAGER, PROTEOMICS: VIROLOGY$52,448
S10 · FY2004 · RR
TYPHOON 9410 GEL/BLOT IMAGER, PROTEOMICS: CANCER$34,965
S10 · FY2004 · RR
TYPHOON 9410 GEL/BLOT IMAGER, PROTEOMICS: CARDIOVASCULAR$26,224
S10 · FY2004 · RR
TYPHOON 9410 GEL/BLOT IMAGER, PROTEOMICS: RENAL$8,742
S10 · FY2004 · RR
EARLY DETECTION OF CANCER BY AFFINITY MASS SPECTROMETRY$415,811
U01 · FY2003 · CA
HTLV-I TAX MEDIATED DEREGULATION OF CELL STATE$180,810
R01 · FY2003 · CA
EARLY DETECTION OF CANCER BY AFFINITY MASS SPECTROMETRY$410,403
U01 · FY2002 · CA
HTLV-I TAX MEDIATED DEREGULATION OF CELL STATE$175,544
R01 · FY2002 · CA
EARLY DETECTION OF CANCER BY AFFINITY MASS SPECTROMETRY$589,400
U01 · FY2001 · CA
HTLV-I TAX MEDIATED DEREGULATION OF CELL STATE$170,431
R01 · FY2001 · CA
HTLV-I TAX MEDIATED DEREGULATION OF CELL STATE$35,600
R01 · FY2001 · CA
HTLV-I TAX MEDIATED DEREGULATION OF CELL STATE$135,159
R01 · FY2000 · CA